FH and renal cell adenocarcinoma: IHC (performed at Mayo ClinicLaboratories, USA) for FH was negative, and there was strong aberrant staining for2SC consistent with an HLRCC-associated (WHO, 2016) or FH-deficient (GUPS, 2021)RCC.